Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1993
04/01/1993CA2116130A1 Diagnosis and therapy for parkinson's disease
04/01/1993CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat
04/01/1993CA2115566A1 Polypeptide inhibitor of the replication of hsu and similar viruses
03/1993
03/31/1993EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof
03/31/1993EP0534742A1 Anti-human milk fat globule humanised antibodies
03/31/1993EP0534731A1 Pressurised aerosol compositions
03/31/1993EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/31/1993EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes
03/31/1993EP0534568A2 Human growth hormone analogues and their use
03/31/1993EP0534544A1 Antifungal agent
03/31/1993EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE
03/31/1993EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0534383A2 Process for preparing human coagulation factor VIII protein complex
03/31/1993EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0534310A1 Combination containing growth factors and polyelectrolytes
03/31/1993EP0534137A2 Kedarcidin antitumor chromophore
03/31/1993EP0533938A1 Composition for rectal administration of difficultly absorbable peptide
03/31/1993EP0533898A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
03/31/1993EP0533872A1 Use of apotransferrin which has accumulated zinc or copper ions to combat the toxic action of endotoxin
03/31/1993EP0533862A1 Recombinant human factor viii derivatives
03/31/1993EP0533846A1 The ciliary neurotrophic factor receptor
03/31/1993EP0533841A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies
03/31/1993EP0533834A1 Intercellular adhesion mediators
03/31/1993EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
03/31/1993EP0533820A1 Pharmaceutical preparation.
03/31/1993EP0533795A1 Composition of and treatment with biologically active peptides having d-amino acid residues
03/31/1993EP0533744A1 Heterocyclic anthracyclione and anthracycline analogs
03/31/1993EP0533690A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
03/31/1993EP0479799A4 Wound healing
03/31/1993EP0470976B1 Processes and compositions for the isolation of human relaxin
03/31/1993EP0466854A4 T cell growth factor
03/31/1993EP0438566A4 Therapeutic peptides
03/31/1993EP0295248B1 Liposome preparation and antibiotic
03/31/1993EP0281604B1 Single polypeptide chain binding molecules
03/31/1993EP0253870B1 Method for producing factor viii:c-type proteins
03/31/1993CN1070344A Composition for sustained and controlled release of medicamentous substances and process for preparing same
03/31/1993CA2079291A1 Activities of heparin binding neurite-outgrowth promoting factor
03/31/1993CA2079290A1 Activities of mk protein
03/31/1993CA2079254A1 Inhibitors of farnesyl protein transferase
03/31/1993CA2079253A1 Inhibitors of farnesyl protein transferase
03/30/1993US5198542 Dna encoding a pitvitary adenylate cyclase activating protein and use thereof
03/30/1993US5198541 Dna encoding bactericidal/permeability-increasing proteins
03/30/1993US5198538 Method for producing immunosuppressive agents
03/30/1993US5198533 Decapeptides
03/30/1993US5198428 Macrophage cytotoxin compositions and methods of preparation
03/30/1993US5198426 Renin inhibitors containing c-terminal dihydroxy amides
03/30/1993US5198425 Inhibitors of bacterial ribonucleotide reductase
03/30/1993US5198424 Functionally active selectin-derived peptides
03/30/1993US5198423 Inhibition of angiogenesis, wound healing
03/30/1993US5198422 Complex With Aromatic Aldehyde, Sustained Release
03/30/1993US5198421 Phosphorylated cyclic lipopeptide
03/30/1993US5198420 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
03/30/1993US5198419 Lactoferrin
03/30/1993US5198417 Methods of treating pancytopenia and AIDS by co-administering EPO and colony stimulating factors
03/30/1993US5198361 Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods
03/30/1993US5198352 Preparation of antibacterial compositions from glycopeptides
03/30/1993US5198350 Viricides
03/30/1993US5198349 Expression vectors with gene coding
03/30/1993US5198347 Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor
03/30/1993US5198346 Generation and selection of novel DNA-binding proteins and polypeptides
03/30/1993US5198344 DNA sequence that encodes the multidrug resistance gene
03/30/1993US5198342 DNA encoding IgA Fc receptors
03/30/1993US5198212 Antiinflammatory agents
03/30/1993US5198211 Method of treating myocardial damage
03/30/1993US5197973 Polypeptide
03/30/1993CA1315480C Phosphopeptides
03/30/1993CA1315479C Platelet-aggregation inhibitor peptide derivatives
03/30/1993CA1315478C Tripeptide with immunostimulating activity
03/30/1993CA1315477C 2-amino acetamide derivatives
03/30/1993CA1315473C 4-piperidinecarboxamide derivatives
03/30/1993CA1315472C Thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein
03/30/1993CA1315231C Kibdelosporangium aridum sk&f-aad-609
03/30/1993CA1315229C Chromatographic purification process
03/30/1993CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc.
03/30/1993CA1315220C Preparation of monoclonal antibodies capable of reacting with human breast carcinoma cells
03/30/1993CA1315219C Monoclonal antibodies against human carcinoembryonic antigen, processes for their production and their use
03/30/1993CA1315200C Sustained-release particulate preparation and process for preparing the same
03/30/1993CA1315149C Process for the preparation of a sterilised casein-based liquid composition
03/29/1993CA2079157A1 Pharmaceutical compositions
03/28/1993CA2079078A1 Antifungal agent
03/27/1993CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them
03/27/1993CA2079042A1 Combination containing growth factors and polyelectrolytes
03/27/1993CA2075453A1 Kedarcidin antitumor chromophore
03/25/1993CA2078721A1 Process for preparing human coagulation factor viii protein complex
03/24/1993EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases
03/24/1993EP0533416A1 Use of IL-5 to treat solid tumors
03/24/1993EP0533408A2 Cosmetics and pharmaceuticals containing extensins
03/24/1993EP0533342A1 Anti-HIV (AIDS) agents
03/24/1993EP0533280A1 Novel medical use for tachykinin antagonists
03/24/1993EP0533226A2 Novel chromophore containing compounds
03/24/1993EP0533210A1 Protein C containing pharmaceutical preparations
03/24/1993EP0533209A1 beta-sympathomimetic Protein C containing pharmaceutical preparation
03/24/1993EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3
03/24/1993EP0533084A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating and preventing myointimal proliferation
03/24/1993EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
03/24/1993EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus
03/24/1993EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity
03/24/1993EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof
03/24/1993EP0532693A1 1,4-diamino-2,3-dihydroxybutanes
03/24/1993EP0532546A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
1 ... 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 ... 3163